|
C14ORF21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63409999999198E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.710820E-01 |
| Normal-vs-Stage2 |
5.814800E-04 |
| Normal-vs-Stage3 |
5.34599997603635E-09 |
| Normal-vs-Stage4 |
3.20020000499355E-08 |
| Stage1-vs-Stage2 |
1.363770E-02 |
| Stage1-vs-Stage3 |
4.59440000044609E-07 |
| Stage1-vs-Stage4 |
2.89539999998034E-06 |
| Stage2-vs-Stage3 |
3.356400E-01 |
| Stage2-vs-Stage4 |
1.749550E-01 |
| Stage3-vs-Stage4 |
5.188200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63121999999793E-05 |
| Normal-vs-AfricanAmerican |
1.841950E-02 |
| Normal-vs-Asian |
9.460400E-01 |
| Caucasian-vs-AfricanAmerican |
8.761200E-01 |
| Caucasian-vs-Asian |
2.466000E-01 |
| AfricanAmerican-vs-Asian |
3.066000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21189999982663E-07 |
| Normal-vs-Female |
3.435900E-02 |
| Male-vs-Female |
6.922900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.857800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.624820E-03 |
| Normal-vs-Age(61-80Yrs) |
1.93370000000082E-05 |
| Normal-vs-Age(81-100Yrs) |
3.967900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.523000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.350000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.506000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.938000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.027600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.378800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.416200E-02 |
| Normal-vs-Grade 2 |
2.839700E-02 |
| Normal-vs-Grade 3 |
1.69526999999059E-05 |
| Normal-vs-Grade 4 |
1.18249854352825E-11 |
| Grade 1-vs-Grade 2 |
2.761900E-02 |
| Grade 1-vs-Grade 3 |
2.239200E-03 |
| Grade 1-vs-Grade 4 |
5.70810000044553E-07 |
| Grade 2-vs-Grade 3 |
1.743580E-02 |
| Grade 2-vs-Grade 4 |
2.44560000028926E-07 |
| Grade 3-vs-Grade 4 |
8.638400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.334800E-01 |
| Normal-vs-ccB subtype |
3.07500003238204E-09 |
| ccA subtype-vs-ccB subtype |
1.47069999512084E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.824700E-04 |
| Normal-vs-N1 |
2.88299999984254E-07 |
| N0-vs-N1 |
2.157800E-02 |
|
|
